Yes. The Univ. AZ study is published. J.M. Snider et al., “Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality,” J. Clinical Investigation, Aug. 24, 2021; https://www.jci.org/articles/view/149236#SEC4. If you read it carefully you'll understand that Ardis is completely misrepresenting …
Yes. The Univ. AZ study is published. J.M. Snider et al., “Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality,” J. Clinical Investigation, Aug. 24, 2021; https://www.jci.org/articles/view/149236#SEC4. If you read it carefully you'll understand that Ardis is completely misrepresenting its conclusions. He first assumes and then asserts that all the patients were on remdesivir and then uses the finding that 100% had phospholipase A2 as evidence that remdesivir is snake venom. That is such poor logic, not to mention lazy research! In fact, many samples were collected before remdesivir was even approved for use. And, Supplemental Table 3 shows that no more than 1/3 of patients had remdesivir or other antiviral. So, what the paper in fact shows is the opposite of what Ardis claims: all patients had PLA2 because it is natural produced by humans in response to pathogens, including in response to SARS-CoV-2/COVID. It was not injected via remdesivir. Yet Ardis cites this study and makes this unfounded assumption and logical leap in most of his presentations. It is a key paper that he cites.
Yes. The Univ. AZ study is published. J.M. Snider et al., “Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality,” J. Clinical Investigation, Aug. 24, 2021; https://www.jci.org/articles/view/149236#SEC4. If you read it carefully you'll understand that Ardis is completely misrepresenting its conclusions. He first assumes and then asserts that all the patients were on remdesivir and then uses the finding that 100% had phospholipase A2 as evidence that remdesivir is snake venom. That is such poor logic, not to mention lazy research! In fact, many samples were collected before remdesivir was even approved for use. And, Supplemental Table 3 shows that no more than 1/3 of patients had remdesivir or other antiviral. So, what the paper in fact shows is the opposite of what Ardis claims: all patients had PLA2 because it is natural produced by humans in response to pathogens, including in response to SARS-CoV-2/COVID. It was not injected via remdesivir. Yet Ardis cites this study and makes this unfounded assumption and logical leap in most of his presentations. It is a key paper that he cites.